Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Qiming Venture Partners
AddedJul 2, 2026
UpdatedJul 2, 2026
Qiming Venture Partners

Qiming Venture Partners

Operating

Qiming Venture Partners is a venture capital firm backing technology and healthcare companies.

Location
Shanghai, Shanghai, CN
Founded
2006
Committed Capital Total
$9.5B
Geographic Focus
regional
Firm
Analysis
Compare
Portfolio
Employees
News
Website

Qiming Venture Partners is a venture capital firm that backs early- and growth-stage companies. The firm invests primarily in technology, healthcare, and consumer businesses.

Its portfolio spans software, artificial intelligence, semiconductors, biotechnology, and consumer internet companies. The firm partners with founders from initial funding through public listings, providing capital alongside industry resources and strategic guidance.

Qiming Venture Partners - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments51
Current Portfolio Count25
Total Portfolio Exits0

Top Investment Stages

Series B12 (27.9%)
Series C11 (25.6%)
Series A10 (23.3%)
IPO5 (11.6%)
Series D5 (11.6%)

Stage Mix

Series B 28%Series C 26%Series A 23%IPO 12%Series D 12%

Concentration shown as share of disclosed investments by stage.

Recent Investments

LongBio Pharma logo

LongBio Pharma

Axera Technology logo

Axera Technology

Alamar Biosciences logo

Alamar Biosciences

Viewtrix Technology logo

Viewtrix Technology

Ailomics Therapeutics logo

Ailomics Therapeutics

Allorion Therapeutics logo

Allorion Therapeutics

Aistarfish Healthcare logo

Aistarfish Healthcare

Ark Biosciences logo

Ark Biosciences

Abogen Biosciences logo

Abogen Biosciences

Aohua Endoscopy logo

Aohua Endoscopy

APT Medical logo

APT Medical

Antengene logo

Antengene

Asieris Pharmaceuticals logo

Asieris Pharmaceuticals

Apollomics logo

Apollomics

Biren Technology logo

Biren Technology

Abbisko Therapeutics logo

Abbisko Therapeutics

Amoy Dx logo

Amoy Dx

Roborock logo

Roborock

Bilibili logo

Bilibili

Berry Genomics logo

Berry Genomics

Xiaomi logo

Xiaomi

Aeonmed logo

Aeonmed

Qiming Venture Partners - Similar Investment Firms

Qiming Venture Partners USA logo

Qiming Venture Partners USA

qimingvcusa.com

Q Venture Partners logo

Q Venture Partners

qventure.partners

Chenhui Venture Partners logo

Chenhui Venture Partners

chvc.com.cn

Q Capital Partners logo

Q Capital Partners

qcapital.co.kr

YuanMing Capital logo

YuanMing Capital

Jinqiu Capital logo

Jinqiu Capital

jinqiucapital.com

Sequoia China logo

Sequoia China

Wei Venture Capital logo

Wei Venture Capital

weibo.com

Sinovation Ventures logo

Sinovation Ventures

Shunwei Capital logo

Shunwei Capital

shunwei.com

Qualcomm Ventures logo

Qualcomm Ventures

Kaiwu Capital logo

Kaiwu Capital

China Growth Capital logo

China Growth Capital

Yunqi Partners logo

Yunqi Partners

Baidu Ventures logo

Baidu Ventures

baidu-venture.com

Qiming Venture Partners - Classification

Also Known As
  • Qiming Weichuang Venture Capital Management (Beijing) Co., Ltd.
Geographic Exposure
  • China Asia
Tags
  • Venture Capital